What is CytomX Therapeutics's net change in cash?

CytomX Therapeutics (CTMX) reported net change in cash of $16.16M in Q1 2026.

How has CytomX Therapeutics's net change in cash changed year-over-year?

CytomX Therapeutics's net change in cash increased by 69.2% year-over-year, from $9.55M to $16.16M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

CytomX Therapeutics CTMX Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

AmgenAMGN

$2.91B+192%

Janux TherapeuticsJANX

-$506K+99.9%

Allogene TherapeuticsALLO

-$21.38M+34.7%

Vor BiopharmaVOR

-$226.61M-610%

Design Therapeutics, Inc.DSGN

-$4.09M+54.1%

Other financials

Income statement

See full

Revenue$10.3M-79.9%

Operating income-$19.7M-187%

Net income-$18.2M-178%

EPS (diluted)-$0.10-137%

Balance sheet

See full

Cash & equivalents$28.8M-39.4%

Total debt$2.9M-65.0%

Total equity$319.9M+1,177%

Total assets$359.4M+265%

Cash flow

See full

Operating cash flow-$25.5M-21.4%

CapEx--100%

Free cash flow-$25.5M-20.7%

Valuation

See full

Market cap$711.89M+94.8%

Enterprise value$685.92M+110%

P/S20×+17.6×

Profitability

See full

Operating margin-181.9%-206pp

Net margin-166.4%-195pp

FCF margin-225.6%-334pp

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×-0.3×

Current ratio10.4×+8.7×

Where this comes from

Reported directly by CytomX Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CytomX Therapeutics's net change in cash?: CytomX Therapeutics (CTMX) reported net change in cash of $16.16M in Q1 2026.
How has CytomX Therapeutics's net change in cash changed year-over-year?: CytomX Therapeutics's net change in cash increased by 69.2% year-over-year, from $9.55M to $16.16M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.